News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
235,873 Results
Type
Article (15138)
Company Profile (19)
Press Release (220716)
Section
Business (62923)
Career Advice (638)
Deals (10341)
Drug Delivery (32)
Drug Development (40422)
Employer Resources (34)
FDA (6721)
Job Trends (5395)
News (120318)
Policy (11692)
Tag
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
2024 Pharm Country Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (1463)
Adcomms (11)
Allergies (28)
Alliances (14094)
ALS (45)
Alzheimer's disease (887)
Antibody-drug conjugate (ADC) (33)
Approvals (6741)
Artificial intelligence (66)
Autoimmune disease (4)
Automation (7)
Bankruptcy (116)
Best Places to Work (4881)
BIOSECURE Act (2)
Biosimilars (14)
Biotechnology (15)
Bladder cancer (35)
Brain cancer (12)
Breast cancer (107)
Cancer (810)
Cardiovascular disease (87)
Career advice (523)
Career pathing (12)
CAR-T (53)
Cell therapy (151)
Cervical cancer (5)
Clinical research (32631)
Collaboration (235)
Compensation (105)
Complete response letters (6)
COVID-19 (983)
CRISPR (16)
C-suite (45)
Cystic fibrosis (45)
Data (1022)
Denatured (1)
Depression (11)
Diabetes (124)
Diagnostics (2316)
Digital health (5)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (47)
Drug pricing (29)
Drug shortages (14)
Duchenne muscular dystrophy (32)
Earnings (28956)
Editorial (6)
Employer branding (1)
Employer resources (31)
Events (34535)
Executive appointments (175)
FDA (7200)
Featured Employer (9)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (223)
Gene editing (40)
Generative AI (6)
Gene therapy (159)
GLP-1 (321)
Government (1936)
Guidances (20)
Healthcare (7753)
Huntington's disease (8)
IgA nephropathy (13)
Immunology and inflammation (25)
Indications (12)
Infectious disease (1039)
Inflammatory bowel disease (47)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (30)
Interviews (85)
IPO (5499)
IRA (12)
Job creations (738)
Job search strategy (480)
Kidney cancer (6)
Labor market (6)
Layoffs (111)
Leadership (5)
Legal (1955)
Liver cancer (26)
Lung cancer (120)
Lymphoma (65)
Machine learning (1)
Management (12)
Manufacturing (64)
MASH (61)
Medical device (4682)
Medtech (4683)
Mergers & acquisitions (4958)
Metabolic disorders (321)
Multiple sclerosis (28)
NASH (19)
Neurodegenerative disease (38)
Neuropsychiatric disorders (8)
Neuroscience (1102)
NextGen: Class of 2025 (2254)
Non-profit (1928)
Northern California (984)
Now hiring (27)
Obesity (151)
Opinion (65)
Ovarian cancer (29)
Pain (46)
Pancreatic cancer (30)
Parkinson's disease (54)
Partnered (4)
Patents (64)
Patient recruitment (41)
Peanut (16)
People (17304)
Pharmaceutical (8)
Pharmacy benefit managers (4)
Phase I (9498)
Phase II (14626)
Phase III (11075)
Pipeline (413)
Podcasts (13)
Policy (27)
Postmarket research (1402)
Preclinical (4496)
Press Release (18)
Prostate cancer (35)
Psychedelics (9)
Radiopharmaceuticals (110)
Rare diseases (156)
Real estate (1028)
Recruiting (13)
Regulatory (8619)
Reports (8)
Research institute (1023)
Resumes & cover letters (103)
Rett syndrome (2)
RSV (16)
Schizophrenia (34)
Series A (28)
Series B (20)
Service/supplier (1)
Sickle cell disease (19)
Southern California (821)
Sponsored (8)
Startups (1020)
Stomach cancer (2)
Supply chain (19)
The Weekly (12)
United States (7795)
Vaccines (210)
Venture capitalists (5)
Webinars (4)
Weight loss (86)
Women's health (7)
Worklife (3)
Date
Today (61)
Last 7 days (326)
Last 30 days (1192)
Last 365 days (14557)
2025 (2213)
2024 (14813)
2023 (16644)
2022 (20115)
2021 (21731)
2020 (20514)
2019 (17241)
2018 (13013)
2017 (12018)
2016 (11124)
2015 (13557)
2014 (9366)
2013 (7162)
2012 (7766)
2011 (8036)
2010 (7110)
Location
Africa (220)
Alabama (13)
Arizona (36)
Arkansas (4)
Asia (11423)
Australia (2385)
California (2115)
Canada (681)
China (148)
Colorado (84)
Connecticut (87)
Delaware (44)
Europe (29599)
Florida (262)
Georgia (76)
Idaho (17)
Illinois (174)
India (8)
Indiana (115)
Iowa (2)
Japan (63)
Kansas (55)
Kentucky (6)
Louisiana (4)
Maine (27)
Maryland (285)
Massachusetts (1361)
Michigan (63)
Minnesota (101)
Missouri (23)
Montana (11)
Nebraska (10)
Nevada (19)
New Hampshire (28)
New Jersey (695)
New Mexico (4)
New York (678)
North Carolina (353)
North Dakota (4)
Northern California (984)
Ohio (75)
Oregon (16)
Pennsylvania (465)
Puerto Rico (4)
Rhode Island (1)
South America (313)
South Carolina (4)
South Dakota (1)
Southern California (821)
Tennessee (36)
Texas (295)
Utah (65)
Virginia (47)
Washington D.C. (13)
Washington State (243)
West Virginia (1)
Wisconsin (12)
235,873 Results for "genae associates".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adeno-associated Virus Gene Therapy Market Size to Reach USD 107.2 Billion by 2035, Impelled by Advancements in Personalized Medicine.
Adeno-associated Virus Gene Therapy Market Outlook 2025-2035:
February 17, 2025
·
11 min read
Career Advice
What You Need to Know to Become a Clinical Research Associate
A clinical research associate is a professional who oversees clinical trials. Here are our top tips on how to become one.
October 28, 2024
·
4 min read
·
Mark Terry
Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative
Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa) today announced its sponsorship of the American Heart Association’s new Addressing Recurrent Pericarditis initiative, a multi-faceted effort to improve quality of care through identification, dissemination, and implementation of best practices for the diagnosis and management of recurrent pericarditis.
June 17, 2024
·
6 min read
Press Releases
Opus Genetics Announces Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
March 5, 2025
·
9 min read
Press Releases
The ALS Association Announces 2025 ‘ALS Nexus’ Conference
January 17, 2025
·
3 min read
Press Releases
The American Diabetes Association and Lilly Collaborate on New Resources for Obesity Care
February 6, 2025
·
2 min read
Press Releases
The American Diabetes Association Announces 2025 Pathway to Stop Diabetes Grant Recipients
February 12, 2025
·
5 min read
BioCapital
Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
Senseonics Holdings, Inc. announced plans to host a business update and analyst event during the American Diabetes Association’s 84th Scientific Sessions in Orlando, FL.
June 13, 2024
·
1 min read
BioCapital
Altimmune Presents Data on the Effect of Pemvidutide on Cardioinflammatory Lipids during Oral Presentation at American Diabetes Association’s 84th Annual Scientific Sessions
Altimmune, Inc., a clinical-stage biopharmaceutical company, presented data on the effect of pemvidutide, its GLP-1/glucagon dual receptor agonist candidate in development for obesity and metabolic dysfunction-associated steatohepatitis, on cardioinflammatory lipids at the American Diabetes Association’s 84th Scientific Sessions.
June 22, 2024
·
5 min read
BioCapital
Altimmune Announces Oral Presentations of Pemvidutide Clinical Data at Upcoming American Diabetes Association’s Scientific Sessions
Altimmune, Inc. today announced oral presentations on pemvidutide, an investigational GLP-1/glucagon dual receptor agonist in development for the treatment of obesity and MASH, at the American Diabetes Association’s (ADA) 84th Scientific Sessions, to be held in Orlando, FL from June 21-24, 2024.
June 18, 2024
·
2 min read
1 of 23,588
Next
